valine and Cardiac Remodeling, Ventricular

valine has been researched along with Cardiac Remodeling, Ventricular in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.08)	18.2507
2000's	33 (68.75)	29.6817
2010's	13 (27.08)	24.3611
2020's	1 (2.08)	2.80

Authors

Authors	Studies
Berry, JD; Coniglio, AC; de Lemos, JA; Drazner, MH; Fox, ER; Garg, S; Grodin, JL; Hall, ME; Khan, SS; Loungani, RS; Mentz, RJ; Pandey, A; Savla, JJ; Segar, MW; Shah, A; Shah, S	1
Bobkova, IN; Chebotareva, NV; Kozlovskaia, LV; Li, OA; Nanchikeeva, ML; Plieva, OK	1
Chen, G; He, QY; Pan, SF; Pan, SQ; Shen, C; Zhang, XM	1
Crane, JA; Jordan, KL; Lerman, A; Lerman, LO; Li, ZL; Pawar, AS; Textor, SC; Zhang, X	1
Chou, YM; Ghasemi, O; Iyer, RP; Jin, YF; Levin, DB; Lindsey, ML; Lopez, EF; Ramirez, TA; Zamilpa, R; Zhang, J	1
Harada, E; Hattori, T; Matsuura, N; Murohara, T; Nagasawa, K; Nagata, K; Niinuma, K; Takahashi, K; Takatsu, M; Watanabe, S	1
Cheng, WP; Lo, HM; Shyu, KG; Wang, BW	1
Akashiba, A; Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y	1
Fu, L; Gao, Y; Han, Y; Li, Y; Ma, D; Shen, J; Wang, F; Wang, Y; Xie, R; Zhou, P	1
Azuma, K; Dejima, T; Ishigami, T; Kokuho, T; Masuda, S; Mitsuhashi, H; Okano, Y; Ozawa, M; Shigenaga, A; Sugano, T; Tamura, K; Tokita, Y; Toya, Y; Tsurumi-Ikeya, Y; Uchino, K; Umemura, S; Wakui, H	1
Geshi, E; Katagiri, T; Mochizuki, S; Nakano, H; Nanjyo, S; Sato, N; Shibata, T; Suzuki, H; Takano, T; Tanaka, K; Yagi, H; Yamazaki, J	1
Arnold, JM; Bourgoun, M; Califf, RM; Ghali, JK; Kober, L; McMurray, JJ; Meris, A; Pfeffer, MA; Skali, H; Solomon, SD; Velazquez, EJ; Verma, A	1
Miura, T; Yuda, S	1
Aihara, K; Akimoto, Y; Daida, H; Kasai, T; Kawamura, M; Kojima, S; Miyauchi, K; Miyazaki, S; Miyazaki, T; Sumiyoshi, M; Suwa, S; Takagi, A	1
Dong, Z; Ge, Z; Geng, J; Kang, W; Liu, G; Sun, Y; Wu, T; Zhang, Y	1
Higashikuni, Y; Hirata, Y; Iwata, H; Nagai, R; Sata, M; Takaoka, M; Tanaka, K	1
Biala, A; Finckenberg, P; Korpi, A; Levijoki, J; Loytainen, M; Martonen, E; Mervaala, E	1
Baek, H; Cho, YR; Choi, SY; Hong, TJ; Hur, SH; Hwang, JY; Kim, KS; Kim, YD; Lee, SG; Park, JS; Park, K; Park, TH; Yang, TH	1
Amigoni, M; Califf, R; Køber, L; Levine, RA; McMurray, JJ; Meris, A; Pfeffer, MA; Solomon, SD; Thune, JJ; Velazquez, E; Verma, A	1
Ardhanari, S; DeMarco, VG; Ferrario, CM; Habibi, J; Hayden, MR; Krueger, C; Pulakat, L; Rehmer, N; Sowers, JR; Whaley-Connell, A	1
Carretero, OA; Kapke, A; Liu, YH; Shesely, EG; Xu, J; Yang, F; Yang, XP	1
Barlera, S; Benza, RL; Chiang, YT; Cohn, JN; Gottlieb, SO; Kleemann, TD; Latini, R; Rosconi, F; Staszewsky, L; Vandervoort, PM; Volpi, A; Wong, M	1
Genda, S; Ichikawa, Y; Kuno, A; Matsumoto, T; Miki, T; Miura, T; Sakamoto, J; Shimamoto, K; Tanno, M	1
Hashimoto, R; Kawahara, S; Matsuzaki, M; Umemoto, S	1
Doi, M; Kobayashi, S; Kohno, M; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Tokuhisa, T; Yamamoto, T; Yano, M	1
Schlosshan, D; Tan, LB; Williams, SG	1
Aknay, N; Anand, I; Barlera, S; Cohn, JN; Glazer, R; Hester, A; Latini, R; Staszewsky, L; Wong, M	1
Jugdutt, BI; Menon, V	1
Dahlöf, B; Kanae, K; Mochizuki, S; Shimizu, M; Tajima, N; Taniguchi, I; Yoshida, S	1
Drexler, H; Landmesser, U	1
Baklanova, NA; Belenkov, IuN; Mareev, VIu; Masenko, VP; Nasonova, SN; Orlova, IaA; Skvortsov, AA; Sychev, AV	1
Akishita, M; Horiuchi, M; Oishi, Y; Oshima, T; Ozono, R; Yoshizumi, M	1
Imamoto, S; Kuno, M; Mochizuki, S; Nagai, M; Okada, T; Seki, S; Taniguchi, I; Taniguchi, M	1
de Gasparo, M	1
Abu-Hijleh, M; Garadah, T; Golbahar, J; Gumaa, K; Kassab, S; Senok, S; Wazir, J	1
Jugdutt, BI	1
Chen, S; Huang, H; Li, R; Liu, P; Tang, F; Wang, P; Zhang, H	1
Cooper, SA; Ferrario, C; Govindarajan, G; Habibi, J; Hayden, MR; Karuparthi, PR; Link, D; Ma, L; Qazi, M; Sowers, JR; Stump, C; Wei, Y; Whaley-Connell, A	1
Azuma, J; Dosaka, N; Iekushi, K; Katsuragi, N; Koibuchi, N; Morishita, R; Nagao, K; Ogihara, T; Sanada, F; Taniyama, Y	1
Burstein, B; Calderone, A; Nattel, S; Qi, XY; Yeh, YH	1
Gaballa, MA; Goldman, S; Guarraia, D; Johnson, N; Thai, H	1
Goldstein, S; Levine, TB; Mishima, T; Sabbah, HN; Sharov, VG; Shimoyama, H; Tanimura, M	1
Iwao, H; Izumi, Y; Kawano, H; Kim, S; Kimoto, M; Yoshiyama, M; Zhan, Y	1
Fukuma, T; Hasegawa, T; Miki, T; Miura, T; Nakano, A; Shimamoto, K; Tsuchida, A	1
Huang, J; Xiang, Y	1
Lau, CP; Tipoe, GL; Wing-Hon Lai, K; Yu, CM	1
Hasegawa, T; Kuno, A; Miki, T; Miura, T; Nishino, Y; Shimamoto, K; Tsuchida, A	1
Akishita, M; Chen, R; de Gasparo, M; Horiuchi, M; Iwai, M; Nakagami, H; Suzuki, J; Wu, L	1

Reviews

4 review(s) available for valine and Cardiac Remodeling, Ventricular

Article	Year
[Angiotensin receptor blockers in chronic heart failure]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:9 Topics: Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Double-Blind Method; Heart Failure; Humans; Hypertension; Japan; Losartan; Myocardial Infarction; Neurotransmitter Agents; Randomized Controlled Trials as Topic; Risk Factors; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling	2003
Chronic heart failure: an overview of conventional treatment versus novel approaches. Nature clinical practice. Cardiovascular medicine, 2005, Volume: 2, Issue:12 Topics: Angiotensin II Type 1 Receptor Blockers; Apoptosis; Cardiac Glycosides; Erythropoietin; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Pacemaker, Artificial; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2005
New basic science initiatives with the angiotensin II receptor blocker valsartan. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:2 Suppl Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atherosclerosis; Cell Proliferation; Endothelium, Vascular; Humans; Inflammation; Tetrazoles; Valine; Valsartan; Vasoconstriction; Ventricular Remodeling	2000
Valsartan in the treatment of heart attack survivors. Vascular health and risk management, 2006, Volume: 2, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Research Design; Secondary Prevention; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling	2006

Trials

11 trial(s) available for valine and Cardiac Remodeling, Ventricular

Article	Year
Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis. Nephron. Clinical practice, 2009, Volume: 112, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptides; Peritoneal Dialysis, Continuous Ambulatory; Pulse; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2009
Inhibitory effect of valsartan against progression of left ventricular dysfunction after myocardial infarction: T-VENTURE study. Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Asian People; Disease Progression; Female; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling	2009
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC. Cardiovascular imaging, 2008, Volume: 1, Issue:5 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Europe; Female; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography; United States; Valine; Valsartan; Ventricular Remodeling	2008
Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:6 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Indoles; Male; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Remodeling	2010
The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial. Trials, 2011, Nov-22, Volume: 12 Topics: Adult; Aged; Angiotensin II Type 2 Receptor Blockers; Clinical Protocols; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Sample Size; Single-Blind Method; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling	2011
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2012, Volume: 25, Issue:5 Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Echocardiography, Doppler, Color; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Monitoring, Physiologic; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Reference Values; Reproducibility of Results; Risk Assessment; ROC Curve; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling	2012
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. Journal of the American College of Cardiology, 2002, Sep-04, Volume: 40, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Tetrazoles; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling	2002
The benefits of valsartan in the treatment of heart failure: results from Val-HeFT. International journal of clinical practice, 2004, Volume: 58, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cost-Benefit Analysis; Double-Blind Method; Heart Failure; Hospitalization; Humans; Risk Factors; Severity of Illness Index; Survival Analysis; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Remodeling	2004
Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data. Journal of the American College of Cardiology, 2004, Jun-02, Volume: 43, Issue:11 Topics: Antihypertensive Agents; Echocardiography; Heart Failure; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Tetrazoles; United States; Valine; Valsartan; Ventricular Remodeling	2004
JIKEI HEART Study--a morbi-mortality and remodeling study with valsartan in Japanese patients with hypertension and cardiovascular disease. Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:4 Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Cardiovascular Diseases; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Japan; Male; Middle Aged; Myocardial Ischemia; Quality of Life; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling	2004
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADK Kardiologiia, 2006, Volume: 46, Issue:7 Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiac Output, Low; Chronic Disease; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Tetrahydroisoquinolines; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Remodeling	2006

Other Studies

33 other study(ies) available for valine and Cardiac Remodeling, Ventricular

Article	Year
Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults. JACC. Heart failure, 2022, Volume: 10, Issue:2 Topics: Adult; Heart Failure; Humans; Isoleucine; Middle Aged; Prealbumin; Troponin I; Valine; Ventricular Remodeling	2022
[General molecular and cellular mechanisms for renal and cardiac remodeling in chronic kidney disease: a target for nephrocardioprotection]. Terapevticheskii arkhiv, 2013, Volume: 85, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Biomarkers; Cardiotonic Agents; Fibrosis; Humans; Kidney; Myocardium; Myofibroblasts; Renal Insufficiency, Chronic; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2013
Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways. Acta pharmacologica Sinica, 2014, Volume: 35, Issue:4 Topics: Administration, Oral; Angiotensin II; Animals; Antioxidants; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypertrophy, Left Ventricular; Isoflavones; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NF-kappa B; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Reactive Oxygen Species; Signal Transduction; Tetrazoles; Ultrasonography; Valine; Valsartan; Ventricular Remodeling	2014
Valsartan regulates myocardial autophagy and mitochondrial turnover in experimental hypertension. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 64, Issue:1 Topics: Animals; Antihypertensive Agents; Autophagy; Blood Pressure; Heart; Hypertension, Renovascular; Mitochondria; Mitochondrial Turnover; Myocardium; Swine; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2014
Aliskiren and valsartan mediate left ventricular remodeling post-myocardial infarction in mice through MMP-9 effects. Journal of molecular and cellular cardiology, 2014, Volume: 72 Topics: Amides; Animals; Antihypertensive Agents; Drug Therapy, Combination; Extracellular Matrix; Female; Fumarates; Gene Expression; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Stroke Volume; Survival Analysis; Systole; Tetrazoles; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling	2014
Comparative effects of valsartan in combination with cilnidipine or amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2015, Volume: 38, Issue:1 Topics: Amlodipine; Animals; Antihypertensive Agents; Dihydropyridines; Drug Evaluation, Preclinical; Drug Therapy, Combination; Heart; Hypertension; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Oxidative Stress; Rats, Inbred Dahl; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2015
MicroRNA-208a Increases Myocardial Endoglin Expression and Myocardial Fibrosis in Acute Myocardial Infarction. The Canadian journal of cardiology, 2015, Volume: 31, Issue:5 Topics: Animals; Atorvastatin; Blotting, Western; Cells, Cultured; Disease Models, Animal; Endoglin; Fibrosis; Gene Expression Regulation; Hemodynamics; Heptanoic Acids; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; Muscle Cells; Myocardial Infarction; Polymerase Chain Reaction; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2015
Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats. Journal of cardiology, 2008, Volume: 52, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Caspase 3; Fibrosis; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; RNA; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan; Ventricular Remodeling	2008
Interventional effect of valsartan on expression of inducible cAMP early repressor and phosphodiesterase 3A in rats after myocardial infarction. European journal of pharmacology, 2009, Jan-14, Volume: 602, Issue:2-3 Topics: Angiotensin Receptor Antagonists; Animals; Apoptosis; Cardiomegaly; Cyclic AMP Response Element Modulator; Cyclic AMP Response Element-Binding Protein; Cyclic Nucleotide Phosphodiesterases, Type 3; Gene Expression Regulation; Heart; Heart Failure; Myocardial Infarction; Myocardium; Rats; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2009
Are treatment effects of ACEI and ARB in post-MI patients homogeneous? Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Asian People; Disease Progression; Humans; Myocardial Infarction; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling	2009
Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2011, Apr-18, Volume: 42, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Endoplasmic Reticulum; Fluorescent Antibody Technique; Male; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction; Tetrazoles; Transcription Factor CHOP; Valine; Valsartan; Ventricular Remodeling	2011
Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice. Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:1 Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Drug Synergism; Fumarates; Heart; Lipid Peroxidation; Male; Mice; Myocardial Infarction; Myocardium; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2012
Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2011, Volume: 62, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Diet, Sodium-Restricted; Echocardiography; Heart; Heart Failure; Heart Rate; Hydrazones; Hypertension; Kidney; Male; Myocytes, Cardiac; Pyridazines; Rats; Rats, Inbred Dahl; RNA, Messenger; Simendan; Sodium Chloride, Dietary; Sodium, Dietary; Tetrazoles; Valine; Valsartan; Vasodilator Agents; Ventricular Remodeling	2011
Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling. Metabolism: clinical and experimental, 2013, Volume: 62, Issue:6 Topics: Aldosterone; Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cell Size; Drug Interactions; Fibrosis; Fumarates; Mice; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Renin; Signal Transduction; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2013
Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:3 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiotonic Agents; Collagen; Enalapril; Heart Rate; Hemodynamics; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Survival Analysis; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2002
Interruption of signal transduction between G protein and PKC-epsilon underlies the impaired myocardial response to ischemic preconditioning in postinfarct remodeled hearts. Molecular and cellular biochemistry, 2003, Volume: 247, Issue:1-2 Topics: Adenosine; Angiotensin II Type 1 Receptor Blockers; Animals; Cytosol; GTP-Binding Proteins; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion; Protein Kinase C; Protein Kinase C-epsilon; Protein Transport; Rabbits; Receptors, Purinergic P1; Signal Transduction; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2003
Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure. Circulation, 2004, Feb-24, Volume: 109, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Signaling; Calcium-Transporting ATPases; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Dogs; Drug Evaluation, Preclinical; Heart Failure; Myocardial Contraction; Norepinephrine; Phosphorylation; Protein Processing, Post-Translational; Receptors, Adrenergic, beta; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Tachycardia, Ventricular; Tacrolimus Binding Proteins; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2004
AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction. Molecular and cellular biochemistry, 2004, Volume: 260, Issue:1-2 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Dogs; Heart Rate; Heart Ventricles; Hemodynamics; Irbesartan; Myocardial Infarction; Myocardial Reperfusion Injury; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Remodeling	2004
AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling. Life sciences, 2006, Dec-03, Volume: 80, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Body Weight; Male; Mice; Mice, Knockout; Myocardial Infarction; Organ Size; Receptor, Angiotensin, Type 2; Survival Rate; Tetrazoles; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling	2006
Combined treatment with valsartan and spironolactone prevents cardiovascular remodeling in renovascular hypertensive rats. International heart journal, 2006, Volume: 47, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Physiological Phenomena; Hypertension, Renovascular; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Wistar; Spironolactone; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2006
The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2006, Volume: 7, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Homocysteine; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Organ Size; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2006
Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan. Pharmacological research, 2007, Volume: 55, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension, Renovascular; Ligation; Male; Malondialdehyde; Membrane Glycoproteins; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Renal Artery; Superoxides; Tetrazoles; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling	2007
Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat. American journal of physiology. Endocrinology and metabolism, 2007, Volume: 293, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Cyclic N-Oxides; Lipid Peroxidation; Male; Mitochondria, Heart; NADPH Oxidases; Oxidative Stress; Protein Subunits; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Renin; Spin Labels; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2007
Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:6 Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Cell Adhesion Molecules; Cell Communication; Cells, Cultured; Disease Models, Animal; Fibroblasts; Gene Expression Regulation; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Random Allocation; Rats; Rats, Inbred Lew; Rats, Wistar; Stress, Mechanical; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2007
Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovascular research, 2007, Dec-01, Volume: 76, Issue:3 Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Fibrillation; Cell Communication; Cell Proliferation; Cells, Cultured; Collagen Type I; Culture Media; Disease Models, Animal; Dogs; Extracellular Matrix; Fibroblasts; Fibronectins; Heterocyclic Compounds, 4 or More Rings; Muscle Contraction; Myocytes, Cardiac; Tachycardia; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2007
Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation. Journal of cardiovascular pharmacology, 2007, Volume: 50, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Heart Failure; In Vitro Techniques; Male; Myocardial Infarction; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors; Valine; Valsartan; Vasodilation; Ventricular Function, Left; Ventricular Remodeling	2007
Effects of AT1-receptor blockade on progression of left ventricular dysfunction in dogs with heart failure. The American journal of physiology, 1999, Volume: 276, Issue:4 Topics: Angiotensin Receptor Antagonists; Animals; Cardiac Output, Low; Disease Progression; Dogs; Dose-Response Relationship, Drug; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling	1999
Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation, 2001, Jan-02, Volume: 103, Issue:1 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Catecholamines; Collagen; Diastole; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Endothelin-1; Gene Expression; Heart Failure; Heart Function Tests; Hydroxyproline; Myocardium; Myosin Heavy Chains; Organ Size; Rats; Rats, Inbred Dahl; Receptors, Angiotensin; RNA, Messenger; Sodium Chloride, Dietary; Survival Rate; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2001
[Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation]. Journal of cardiology, 2001, Volume: 37, Issue:2 Topics: Angiotensin Receptor Antagonists; Animals; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2001
Effect of valsartan and fosinopril on catecholamine-induced cardiac hypertrophy. Acta pharmacologica Sinica, 2000, Volume: 21, Issue:9 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium-Transporting ATPases; Collagen; Female; Fosinopril; Hypertrophy, Left Ventricular; Male; Myocardium; Norepinephrine; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2000
Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. Journal of the American College of Cardiology, 2001, Volume: 38, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Collagen; Drug Combinations; Fibrosis; Fosinopril; Male; Myocardial Infarction; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan; Ventricular Remodeling	2001
Blockade of angiotensin II type 1 receptors suppressed free radical production and preserved coronary endothelial function in the rabbit heart after myocardial infarction. Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:1 Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelium, Vascular; Enzyme Inhibitors; Free Radicals; Hemodynamics; In Vitro Techniques; Lipid Peroxides; Male; Myocardial Infarction; Myocardium; Nitroprusside; omega-N-Methylarginine; Oxygen; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tiopronin; Valine; Valsartan; Vasodilator Agents; Ventricular Remodeling	2002
Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arteriosclerosis, thrombosis, and vascular biology, 2002, Volume: 22, Issue:1 Topics: Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Coronary Vessels; Male; Mice; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan; Ventricular Remodeling	2002